Archives: Treatments

FDA-approved lung cancer treatment

Mobocertinib

Targeted TherapyApproved for: NSCLCBiomarker: EGFR Exon20 Insertion Mobocertinib (EXKIVITY) is the first oral therapy specifically designed for patients with EGFR Exon20 insertion+ NSCLC Related Research News A Multicenter Study on the Efficacy of Immunotherapy in Advanced Lung Cancer PatientsBMS...
Read More
|
January 5, 2022
|
Treatment

Sotorasib

Targeted TherapyApproved for: NSCLCBiomarker: KRAS G12C Sotorasib is the first treatment for adult patients with non–small cell lung cancer whose tumors harbor KRAS G12C mutations and who have received at least 1 prior systemic therapy. Related Research News A...
Read More
|
January 5, 2022
|
Treatment

Cisplatin

ChemotherapyApproved for: NSCLC, SCLC Cisplatin is a FDA-approved Chemotherapy treatment Related Research News A Multicenter Study on the Efficacy of Immunotherapy in Advanced Lung Cancer PatientsBMS presents positive four-year results for Opdivo combination in lung cancerLung cancer pill cuts...
Read More
|
June 1, 2021
|
Treatment

Methotrexate Sodium (Trexall/Xatmep)

ChemotherapyApproved for: NSCLC, SCLC Methotrexate Sodium (Trexall/ Xatmep) Related Research News A Multicenter Study on the Efficacy of Immunotherapy in Advanced Lung Cancer PatientsBMS presents positive four-year results for Opdivo combination in lung cancerLung cancer pill cuts risk of...
Read More
|
June 1, 2021
|
Treatment

Doxorubicin Hydrochloride (Totect/Zinecard)

ChemotherapyApproved for: NSCLC, SCLC Etoposide is a FDA-approved Chemotherapy for non-small cell lung cancer (NSCLC) that is metastatic or small cell lung cancer  (SCLC) that is metastatic. Related Research News BMS presents positive four-year results for Opdivo combination in...
Read More
|
June 1, 2021
|
Treatment

Etoposide

ChemotherapyApproved for: SCLC Etoposide is a FDA-approved Chemotherapy for small cell lung cancer (SCLC). Related Research News A Multicenter Study on the Efficacy of Immunotherapy in Advanced Lung Cancer PatientsBMS presents positive four-year results for Opdivo combination in lung...
Read More
|
June 1, 2021
|
Treatment

Gemcitabine Hydrochloride (Gemzar/Infugem)

ChemotherapyApproved for: NSCLC Gemcitabine Hydrochloride (Gemzar/ Infugem) approved Chemotherapy for Non-small cell lung cancer (NSCLC) that is locally advanced or metastatic and cannot be removed by surgery. It is used with cisplatin. Related Research News A Multicenter Study on...
Read More
|
June 1, 2021
|
Treatment

Carboplatin (Paraplatin)

ChemotherapyApproved for: NSCLC, SCLC Carboplatin + paclitaxel (carbo taxol) is given to shrink tumors and improve symptoms of lung cancer. If the disease is not metastatic (spread to areas of the body outside the lungs), carboplatin + paclitaxel may...
Read More
|
June 1, 2021
|
Treatment

Docetaxel (Taxotere)

ChemotherapyApproved for: NSCLC Docetaxel (Taxotere) approved Chemotherapy for Non-small cell lung cancer (NSCLC) that is locally advanced or has metastasized. It is used: Alone in patients whose cancer has not gotten better after platinum chemotherapy With cisplatin in patients whose...
Read More
|
June 1, 2021
|
Treatment

Gefitinib (Iressa)

Targeted TherapyApproved for: NSCLCBiomarker: EGFR Gefitinib (Iressa) approved Targeted Therapy for non-small cell lung cancer (NSCLC) that has metastasized (spread to other parts of the body). It is used as first-line treatment in patients whose tumors have certain EGFR...
Read More
|
June 1, 2021
|
Treatment
1 2 3 … 6